Bioequivalence Study of Mofest® 400mg (Moxifloxacin) Tablet With Avelox® 400mg (Moxifloxacin) Tablet in Healthy Pakistani Subjects

Clinical trial NCT04873570 · COMPLETED

Trial details

NCT number: NCT04873570
Sponsor: University of Karachi
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Individuals Bioequivalence Study

Start date: 2021-05-28
Primary completion: 2021-06-08
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.